Kidney Cancer Clinical Trial

Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing

Summary

This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.

View Full Description

Full Description

PRIMARY OBJECTIVES:

The overall objective of the PE-CGS Research Center is to develop culturally appropriate, respectful, trusted, and collaborative means to engage and recruit American Indians affected by cancer (newly diagnosed cancer patients, patients undergoing cancer treatment, and cancer survivors) for molecular characterization of their tumors.

The clinical trial is embedded in the Patient Engagement Unit (PEU) jointly with the Engagement Optimization Unit (EOU)

The specific objectives for the PEU are to:

Conduct direct participant engagement with cancer patients/survivors, community advisors, and partners to refine and optimize methods/processes;
Identify, recruit and consent eligible AI cancer patients/survivors;
Implement tissue acquisition, epidemiologic, behavioral, and clinical data collection, conduct continuous assessment of performance benchmarks;
Return clinical grade and clinically useful genomic data to participants with navigation to counseling and clinical resources as warranted and as they select.

The specific objectives of the EUO are to:

Finalize consenting process and informed consent by direct engagement of AI cancer patients, survivors, healthcare providers, genetic counselors, consenting staff, tribal and spiritual leaders and tribal governance;
Determine AI cancer patients' and survivors' knowledge, attitudes, cultural beliefs, information needs, and communication preferences and practices regarding clinical genomics testing;
Determine AI cancer patients' and survivors' perspectives on strategies to engage and recruit participants for clinical genomics testing.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

The PE-CGS Research Center is only recruiting and sequencing tumors for adult-onset cancers (patients and survivors) among the American Indian Tribes, Nations, and Pueblos of New Mexico and adjacent states
Male or female adults (18 years) or older
Cancer patient undergoing active treatment or a cancer survivor
Self-identify as American Indian

Exclusion Criteria:

Cognitively impaired
Adults unable to consent for themselves
Individuals who are not yet adults
Prisoners

Study is for people with:

Kidney Cancer

Estimated Enrollment:

1001

Study ID:

NCT06207864

Recruitment Status:

Recruiting

Sponsor:

New Mexico Cancer Care Alliance

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of New Mexico Comprehensive Cancer Center
Albuquerque New Mexico, 87102, United States More Info
Kelsey Ayers, BS
Contact
505-272-5062
[email protected]
Koby Blackwater
Contact
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

1001

Study ID:

NCT06207864

Recruitment Status:

Recruiting

Sponsor:


New Mexico Cancer Care Alliance

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.